No abstract available
MeSH terms
-
Carcinoma, Hepatocellular / etiology*
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetes Mellitus, Type 2 / physiopathology
-
Female
-
Hepatitis C, Chronic / complications*
-
Humans
-
Hyperinsulinism / complications*
-
Hyperinsulinism / drug therapy
-
Hyperinsulinism / physiopathology
-
Hypoglycemic Agents / adverse effects
-
Insulin / adverse effects
-
Insulin Resistance
-
Liver Diseases, Alcoholic / complications*
-
Liver Neoplasms / etiology*
-
Male
-
Metformin / adverse effects
-
Odds Ratio
-
Retrospective Studies
-
Risk Assessment
-
Risk Factors
-
Sulfonylurea Compounds
Substances
-
Hypoglycemic Agents
-
Insulin
-
Sulfonylurea Compounds
-
Metformin